4//SEC Filing
Baxalta Inc 4
Accession 0000899243-15-003075
CIK 0001620546operating
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 5:48 PM ET
Size
9.9 KB
Accession
0000899243-15-003075
Insider Transaction Report
Form 4
Baxalta IncBXLT
LEONARDI JACOPO
EVP and President, Immunology
Transactions
- Award
Common Stock, par value $0.01 per share
2015-08-11+44→ 27,921 total - Award
Common Stock, par value $0.01 per share
2015-08-11+56→ 27,977 total
Holdings
- 1,091(indirect: By 401(k))
Common Stock, par value $0.01 per share
Footnotes (4)
- [F1]Represents shares earned from the performance share unit award granted on March 5, 2013 pursuant to the Equity Plan adopted by Baxter International Inc. ("Baxter") as of such date. The award provides that fifty percent of the performance share units are earned based on Baxter's Return on Invested Capital (ROIC) performance annually over a three-year period with one-third of the ROIC performance share units allocated to each one-year period. (Continue in Footnote 2)
- [F2]In connection with the spin-off of Baxalta Incorporated ("Baxalta") from Baxter, the 2015 performance period was adjusted so that the vesting of the third one-third of the ROIC performance share units allocated to that year will vest based upon a percentage determined by adding (i) the percentage determined by the extent to which Baxter, prior to giving effect to the spin-off, achieves the ROIC performance target for the first six months of 2015, plus (ii) in the case of the reporting person, the percentage determined by the extent to which Baxalta, after giving effect to the spin-off, achieves its ROIC performance targets for the last six months of 2015, and dividing such sum by two. The number of shares reported represents the shares earned based on Baxter's ROIC during the performance period of January 1, 2015 to June 30, 2015. These shares vest after the end of the relevant three-year ROIC performance period.
- [F3]Represents shares earned from the performance share unit award granted on March 4, 2014 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on Baxter's Return on Invested Capital (ROIC) performance annually over a three-year period with one-third of the ROIC performance share units allocated to each one-year period. (Continue in Footnote 4)
- [F4]In connection with the spin-off of Baxalta from Baxter, the 2015 performance period was adjusted so that the vesting of the second one-third of the ROIC performance share units allocated to that year will vest based upon a percentage determined by adding (i) the percentage determined by the extent to which Baxter, prior to giving effect to the spin-off, achieves the ROIC performance target for the first six months of 2015, plus (ii) in the case of the reporting person, the percentage determined by the extent to which Baxalta, after giving effect to the spin-off, achieves its ROIC performance targets for the last six months of 2015, and dividing such sum by two. The number of shares reported represents the shares earned based on Baxter's ROIC during the performance period of January 1, 2015 to June 30, 2015. These shares vest after the end of the relevant three-year ROIC performance period.
Documents
Issuer
Baxalta Inc
CIK 0001620546
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001620546
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 5:48 PM ET
- Size
- 9.9 KB